MARY BEEGLE: Open Payments
NPI 1659488419 · SEDALIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 7 payments from 6 companies in 2025. Trend: 2023 $299 · 2024 $179 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $91 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, Auvelity, CAPLYTA, INGREZZA, TRINTELLIX, REXULTI.
Industry payments across MO — which companies pay providers there.
